6Dodd MJ. The pathogenesis and characterization of oral mucositisassociated with cancer therapy C Jl- Oncology Nursing Forum,2004,31(4):5 - 11.
7Li E,Trovato JA. New developments in management of oral mu-cositis in patients with head and neck cancer or receiving targetedanticancer therapies[J]. Am J Health Syst Pharm, 2012 , 69 ( 12):1031 - 1037.
8Keefe DM,Schubert MM,Elting LS,et al. Updated clinical prac-tice guidelines for the prevention and treatment of mucositis[J].Cancer,2007,109(5) :820 -831.
9Miinter MW, Karger CP, Hoffner SG, et al. Evaluation of salivarygland function after treatment of head - and - neck tumors withintensity - modulated radiotherapy by quantitative pertechnetateacintigraphy[j]. Int J Radiat Oncol Biol Phys,2004,58(1) :175.
10Sheibani KM, Marl AR, Moghaddam S, et al. Efficacy of benzydamine oral rinse in prevention and manage- ment of radiation- induced oral mueositis:A double - blind placebo - controlled randomized clinical trial[J]. Asia Pac J Clin Oneol,2014,12(45) :152 - 155.
